Dr. Johannes Tanner joined the Department of Medicine in the Division of Oncology as an Instructor in July, 2018.
Dr. Tanner’s research efforts are focused on developing novel immunotherapeutic strategies that enhance anti-tumor immunity, especially in the brain. Clinically, he sees patients with skin and brain tumors as well as patients enrolled in early phase immunotherapy studies through the Developmental Therapeutics group.